Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reijonen, H.
Right arrow Articles by Nepom, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reijonen, H.
Right arrow Articles by Nepom, G. T.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 10 1621-1626, Copyright © 2000 by American Diabetes Association

ARTICLES

GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65

H Reijonen, TL Daniels, A Lernmark and GT Nepom
Virginia Mason Research Center, Benaroya Research Institute, Seattle, Washington 981010, USA. reijonen@vmresearch.org

GAD65 autoantibodies (GAD65Ab) are highly prevalent in type 1 diabetes, but their functional role in the pathogenesis of the disease and their relationship to T-cell reactivity to GAD65 is still unclear. We tested the hypothesis that GAD65Ab modulate presentation of GAD65 to T-cells. T-cell hybridoma T33.1, which recognizes the GAD65 274-286 epitope in the context of HLA-DRB 1*0401, was incubated with antigen-presenting cells exposed to recombinant human GAD65 alone or complexed with GAD65Ab' or GAD65Ab- sera. Stimulation of the T33.1 hybridoma was greatly enhanced by multiple GAD65Ab+ sera. The enhancement effect was most prominent with sera from patients with high GAD65 autoantibody levels. Sera from GAD65Ab- subjects had no effect. The correlation between T-cell stimulation and GAD65Ab levels was not absolute, suggesting that other variables such as autoantibody recognition of different regions of GAD65 and variable effects on processing of the 274-286 epitope may contribute. Uptake of antibody-complexed GAD65 was Fc receptor (FcR)-mediated because the enhancement of presentation was inhibited by monoclonal antibodies against FcR. Our results support the hypothesis that GAD65Ab modulate presentation of GAD65 to T-cells. Increased antigen uptake and heterogeneity in the autoantibody specificity may provide a mechanism for antibody-facilitated T-cell response influencing the progression of type 1 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
G. Fenalti, C. S. Hampe, Y. Arafat, R. H.P. Law, J. P. Banga, I. R. Mackay, J. C. Whisstock, A. M. Buckle, and M. J. Rowley
COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of Autoreactivity
Diabetes, May 1, 2008; 57(5): 1293 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Martinuzzi, G. Novelli, M. Scotto, P. Blancou, J.-M. Bach, L. Chaillous, G. Bruno, L. Chatenoud, P. van Endert, and R. Mallone
The Frequency and Immunodominance of Islet-Specific CD8+ T-cell Responses Change after Type 1 Diabetes Diagnosis and Treatment
Diabetes, May 1, 2008; 57(5): 1312 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. R. Kim, E. Y. Kim, J. Cerny, and K. D. Moudgil
Antibody Responses to Mycobacterial and Self Heat Shock Protein 65 in Autoimmune Arthritis: Epitope Specificity and Implication in Pathogenesis
J. Immunol., November 15, 2006; 177(10): 6634 - 6641.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Quaratino, J. Ruf, M. Osman, J. Guo, S. McLachlan, B. Rapoport, and M. Londei
Human Autoantibodies Modulate the T Cell Epitope Repertoire but Fail to Unmask a Pathogenic Cryptic Epitope
J. Immunol., January 1, 2005; 174(1): 557 - 563.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. S. Wong, L. Wen, M. Tang, M. Ramanathan, I. Visintin, J. Daugherty, L. G. Hannum, C. A. Janeway Jr, and M. J. Shlomchik
Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD Mouse
Diabetes, October 1, 2004; 53(10): 2581 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Y. Setiady, P. Pramoonjago, and K. S. K. Tung
Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex
J. Immunol., July 15, 2004; 173(2): 1051 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Dromey, S. M. Weenink, G. H. Peters, J. Endl, P. J. Tighe, I. Todd, and M. R. Christie
Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants
J. Immunol., April 1, 2004; 172(7): 4084 - 4090.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes, January 1, 2004; 53(1): 250 - 264.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. J. Padoa, J. P. Banga, A.-M. Madec, M. Ziegler, M. Schlosser, E. Ortqvist, I. Kockum, J. Palmer, O. Rolandsson, K. A. Binder, et al.
Recombinant Fabs of Human Monoclonal Antibodies Specific to the Middle Epitope of GAD65 Inhibit Type 1 Diabetes-Specific GAD65Abs
Diabetes, November 1, 2003; 52(11): 2689 - 2695.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kotani, M. Nagata, H. Moriyama, M. Nakayama, K. Yamada, S. A. Chowdhury, S. Chakrabarty, Z. Jin, H. Yasuda, and K. Yokono
Detection of GAD65-Reactive T-Cells in Type 1 Diabetes by Immunoglobulin-Free ELISPOT Assays
Diabetes Care, August 1, 2002; 25(8): 1390 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. C. Jaume, S. L. Parry, A.-M. Madec, G. Sonderstrup, and S. Baekkeskov
Suppressive Effect of Glutamic Acid Decarboxylase 65-Specific Autoimmune B Lymphocytes on Processing of T Cell Determinants Located Within the Antibody Epitope
J. Immunol., July 15, 2002; 169(2): 665 - 672.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Bearzatto, H. Naserke, S. Piquer, K. Koczwara, V. Lampasona, A. Williams, M. R. Christie, P. J. Bingley, A.-G. Ziegler, and E. Bonifacio
Two Distinctly HLA-Associated Contiguous Linear Epitopes Uniquely Expressed Within the Islet Antigen 2 Molecule Are Major Autoantibody Epitopes of the Diabetes-Specific Tyrosine Phosphatase-Like Protein Autoantigens
J. Immunol., April 15, 2002; 168(8): 4202 - 4208.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. Noorchashm, S. A.W. Greeley, A. Naji, N. R. Farid, B. O. Roep, H. Kolb, and S. Martin
B-Cell Deficiency and Type 1 Diabetes
N. Engl. J. Med., February 14, 2002; 346(7): 538 - 539.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Hulbert, B. Riseili, M. Rojas, and J. W. Thomas
Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice
J. Immunol., November 15, 2001; 167(10): 5535 - 5538.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Martin, D. Wolf-Eichbaum, G. Duinkerken, W. A. Scherbaum, H. Kolb, J. G. Noordzij, and B. O. Roep
Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency
N. Engl. J. Med., October 4, 2001; 345(14): 1036 - 1040.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.